Can nail brittleness be an adverse effect of Elexacaftor Tezacaftor Ivacaftor

Recent advances in cystic fibrosis therapeutics have resulted in the development of CFTR modulators that have led to great improvements in CF care.

Authors

Publication Details

Journal
Annals of Case Reports and Medical Images
Published
2024-09-23
DOI
https://doi.org/10.52768/3065-7849/1008
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Can nail brittleness be an adverse effect of Elexacaftor Tezacaftor Ivacaftor

Argyri Petrocheilou
Annals of Case Reports and Medical Images
Cystic Fibrosis Research Advances
article

Can nail brittleness be an adverse effect of Elexacaftor Tezacaftor Ivacaftor

Argyri Petrocheilou
article en

Abstract

Recent advances in cystic fibrosis therapeutics have resulted in the development of CFTR modulators that have led to great improvements in CF care.

Annals of Case Reports and Medical ImagesVol. 1(1)
Openalex Percentile: Top 54%
Cystic Fibrosis Research Advances
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Can nail brittleness be an adverse effect of Elexacaftor Tezacaftor Ivacaftor — Argyri Petrocheilou · Annals of Case Reports and Medical Images (2024) | TGRS Research Map | TGRS